We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ONON:NYSEOn Holding AG Analysis

Data as of 2026-06-12 - not real-time

$39.21

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

On Holding delivered a record Q1 2026 with net sales exceeding CHF 830 million and a 26.4% year‑over‑year increase, pushing gross margins to ~64% and operating margins above 14%, underscoring the brand’s strong pricing power. However, the stock trades at $39.21, more than double the DCF‑derived fair value of $18.6 and carries a forward P/E of 18.2 versus a trailing P/E of 41.7, indicating significant overvaluation. Technicals are mixed: the price sits just below the 20‑day SMA ($38.47) and the 50‑day SMA ($36.43) but remains under the 200‑day SMA ($41.76), while the MACD histogram is negative and the signal line is bearish, suggesting short‑term downside pressure. Volume is on a decreasing trend, and the stock hovers near the $41.41 resistance level with a support cushion around $35.31.
Despite an analyst consensus of “Buy” and insider purchases that signal confidence, the combination of high beta (≈1.5), 30‑day volatility over 37%, and exposure to multiple currencies and geopolitically diverse markets amplifies risk. The consumer‑cyclical nature of the footwear sector adds sensitivity to discretionary spending, while the company’s debt‑to‑equity of ~30% and lack of dividend further limit downside protection. Investors should weigh the robust growth narrative against the pronounced valuation premium and technical weakness when forming a position.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram and signal line
  • Price near resistance with decreasing volume
  • Current valuation far above DCF fair value

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong Q1 revenue growth and margin expansion
  • Guidance of ≥23% constant‑currency net sales growth
  • Insider buying indicating management confidence

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Sustainable brand positioning in the premium performance footwear market
  • Net cash position exceeding total debt
  • Elevated beta and volatility that may temper upside

Key Metrics & Analysis

Financial Health

Revenue Growth14.50%
Profit Margin8.02%
P/E Ratio41.7
ROE15.50%
ROA9.68%
Debt/Equity30.59
P/B Ratio5.9
Op. Cash Flow$400.7M
Free Cash Flow$240.1M

Technical Analysis

TrendNeutral
RSI57.6
Support$35.31
Resistance$41.41
MA 20$38.47
MA 50$36.43
MA 200$41.76
MACDBearish
VolumeDecreasing
Fear & Greed Index87.29

Valuation

Fair Value$18.62
Target Price$52.63
Upside/Downside34.23%
GradeOvervalued
TypeBlend

Risk Assessment

Beta1.53
Volatility37.29%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.